Connor, Clark & Lunn Investment Management Ltd. Pulmonx Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Pulmonx Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 83,941 shares of LUNG stock, worth $723,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,941
Previous 57,953
44.84%
Holding current value
$723,571
Previous $480,000
18.54%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$47.5 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$26.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$19.7 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$13.2 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $321M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...